ENTRY       D12709                      Drug
NAME        Dalmitamig (USAN)
FORMULA     C6464H9967N1705O2026S40
EXACT_MASS  145172.8131
MOL_WEIGHT  145262.1107
SEQUENCE    (Heavy chain)
            QVQLQESGPG LVKPSETLSL TCTVSGGSIS SYYWSWIRQP PGKGLEWIGY IYYSGITHYN
            PSLKSRVTIS VDTSKIQFSL KLSSVTAADT AVYYCARWGV RRDYYYYGMD VWGQGTTVTV
            SSASTKGPSV FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT KTYTCNVDHK PSNTKVDKRV ESKYGPPCPP CPAPPVAGPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE
            GNVFSCSVMH EALHNRFTQK SLSLSPGK
            (heavy chain)
            QVQLQESGPG LVKPSETLSL TCTVSGDSII TFYWSWIRQP PGRGLEWIGY IYYSGITNYN
            PSLKSRVTIS VDTSKNQVSL KLSSVTAADT AVYYCARVSE DSYFHYGMDV WGQGTTVTVS
            SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPPVAGPSV
            FLFPPKPKDT LMISRTPEVT CVVVDVSQED PEVQFNWYVD GVEVHNAKTK PREEQFNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKGLPS SIEKTISKAK GQPREPQVYT LPPSQEEMTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSRL TVDKSRWQEG
            NVFSCSVMHE ALHNHYTQKS LSLSLGK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SSYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSPWTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H95, H136-L215, H149-H205, H228-h227, H231-h230, H262-H322, H368-H426, h22-h95, h135-L'215, h148-h204, h261-h321, h367-h425, L23-L89, L135-L195, L'23-L'89, L'135-L'195)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody, bispecific antibody
COMMENT     Treatment of solid tumors
TARGET      EGFR [HSA:1956] [KO:K04361]
            CD28 [HSA:940] [KO:K06470]
  PATHWAY   hsa04151(1956)  PI3K-Akt signaling pathway
            hsa04630(1956)  JAK-STAT signaling pathway
            hsa04660(940)  T cell receptor signaling pathway
            hsa05235(1956+940)  PD-L1 expression and PD-1 checkpoint pathway in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR
                 D12709  Dalmitamig (USAN)
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD28
                 D12709  Dalmitamig (USAN)
DBLINKS     CAS: 2765077-69-6
///
